ERBB2 and neoplasm: In another assay with additional short-term expanded γδ T cell lines of three different donors as effector cells and HER2-expressing PancTu-I cells, we analyzed in parallel HER2-negative, CD20-positive Raji tumor cell line as target cells to prove specificity of the tribody [(HER2)2xCD16].